RGD Peptides Regulate the Specific Adhesion Scheme of Osteoblasts to Hydroxyapatite but not to Titanium

Abstract

Hydroxyapatite (HA) is a bioactive dental implant material which accelerates bone formation on its surface. The mechanism of this acceleration is not clear. The elucidation of the cell adhesion might be the key to the understanding of the bioactive mechanism of HA. In this study, we analyzed the adhesion of HOS human osteoblasts onto HA and titanium to find the particular adhesion to HA. In short-term cultures in fetal bovine serum-pre-coated materials, a significantly higher number of cells adhered to HA than to titanium. In addition, serum-free conditions with phosphate-buffered saline pre-coating or bovine serum albumin pre-coating materials were tested. The results were nearly the same among all pre-coating conditions, suggesting that the quantity of cell adhesion was not affected by serum components. However, in the morphological observations by SEM, the form of adhesion was found to differ among pre-coating conditions. The osteoblasts tightly adhered and spread onto both HA and titanium with serum pre-coating, whereas the cells loosely adhered and did not spread without serum. To evaluate the Arg-Gly-Asp (RGD) sequence-specific adhesion, we used synthetic RGD peptides for a competitive inhibition test. The results showed that RGD peptides remarkably inhibited the tight adhesion and spreading of osteoblasts onto HA, whereas they did not strongly inhibit adhesion and spreading onto titanium. These results demonstrate that the regulation of cell adhesion to HA is different from that to titanium. Our study suggests that the RGD-containing serum proteins might have a major role in regulating the specific adhesion of osteoblasts to HA, and in inducing enhanced cell growth and differentiation.

Keywords

RGD peptide adhesion osteoblast hydroxyapatite titanium.

Get full access to this article

View all access options for this article.

References

Bagambisa FB , Joos U. , Schilli W. (1990). Interaction of osteogenic cells with hydroxylapatite implant materials in vitro and in vivo. Int Oral Maxillofac Implants 5:217-226.

Block MS , Kent JN , Kay JF (1987). Evaluation of hydroxyapatite-coated titanium dental implants in dogs. J Oral Maxillofac Surg 45:601-607.

Block MS , Finger IM , Fontenot MG , Kent JN ( 1989). Loaded hydroxyapatite-coated and grit-blasted titanium implants in dogs. Int J Oral Maxillofac Implants 4:219-225.

Bowers KT , Keller JC , Randolph BA , Wick DG , Michaels CM (1992). Optimization of surface micromorphology for enhanced osteoblast responses in vitro. Int J Oral Maxillofac Implants 7:302-310.

Buchs AU , Hahn J. , Vassos DM (1995). Efficacy of threaded hydroxyapatite-coated implants placed in the anterior mandible. Implant Dent 4:272-275.

Burridge K. , Fath K. , Kelly T. , Nuckolls G. , Turner C. (1988). Focal adhesions: Transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann Rev Cell Biol 4:487-525.

Buser D. , Schenk RK , Steinemann S. , Fiorellini JP , Fox CH , Stich H. (1991). Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res 25:889-902.

Chou L. , Firth JD , Uitto VJ , Brunette DM (1995). Substratum surface topography alters cell shape and regulates fibronectin mRNA level, mRNA stability, secretion and assembly in human fibroblasts. J Cell Sci 108:1563-1573.

Clark EA , Brugge JS (1995). Integrins and signal transduction pathways: the road taken. Science 268:233-239.

10.

Hjørting-Hansen E. , Worsaae N. , Lemons JE (1990). Histologic response after implantation of porous hydroxylapatite ceramic in humans. Int J Oral Maxillofac Implants 5:255-263.

11.

Komm BS , Terpening CM , Benz DJ , Graeme KA , Gallegos A. , Korc M. , et al. (1988). Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-84.

12.

Lozada JL , James RA , Boskovic M. (1993). HA-coated implants: warranted or not? Compend Contin Educ Dent 15(Suppl):S539-S543.

13.

Luyten FP , Cunningham NS , Vukicevic S. , Paralkar V. , Ripamonti U. , Reddi AH (1992). Advances in osteogenin and related bone morphogenetic proteins in bone induction and repair. Acta Orthop Belg 58:263-267.

14.

Massas R. , Pitaru S. , Weinreb MM (1993). The effects of titanium and hydroxyapatite on osteoblastic expression and proliferation in rat parietal bone cultures. J Dent Res 72:1005-1008.

15.

Mulkins MA , Manolagas SC , Deftos LJ , Sussman HH (1983). 1,25-dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells. J Biol Chem 258:6219-6225.

16.

Nimb L. , Gotfredsen K. , Steen Jensen J. (1993). Mechanical failure of hydroxyapatite-coated titanium and cobalt-chromium-molybdenum alloy implants. An animal study. Acta Orthop Belg 59:333-338.

17.

Ruoslahti E. , Pierschbacher MD (1987). New perspectives in cell adhesion: RGD and integrins . Science 238:491-497.

18.

Saadoun AP , LeGall ML (1992). Clinical results and guidelines on Steri-Oss endosseous implants. Int J Periodontol Rest Dent 12:486-495.

19.

Schneider G. , Burridge K. (1994). Formation of focal adhesions by osteoblasts adhering to different substrata. Exp Cell Res 214:264-269.

20.

Schwartz Z. , Boyan BD (1994). Underlying mechanisms at the bone-biomaterial interface. J Cell Biochem 56:340-347.

21.

Singer II , Kawka DW , Scott S. , Mumford RA , Lark MW ( 1987). The fibronectin cell attachment sequence Arg-Gly-Asp-Ser promotes focal contact formation during early fibroblast attachment and spreading . J Cell Biol 104:573-584.

22.

Takeshita F. , Kuroki H. , Yamasaki A. , Suetsugu T. (1995). Histopathologic observation of seven removed endosseous dental implants. Int J Oral Maxillofac Implants 10:367-372.

23.

Taylor JC , Driscoll CF , Cunningham MD (1996). Failure of a hydroxyapatite-coated endosteal dental implant: a clinical report. J Prosthet Dent 75:353-355.

24.

Wennerberg A. , Albrektsson T. , Andersson B. (1993). Design and surface characteristics of 13 commercially available oral implant systems. Int J Oral Maxillofac Implants 8:622-633.